in Business

Philip Morris to Take $220 Million Loss on Sale of Inhaled-Medicine Unit

364 Views

Philip Morris to Take 0 Million Loss on Sale of Inhaled-Medicine Unit




Philip Morris stated it expects to document a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings because it retools its pharmaceutical enterprise.

Report

Comments

Express your views here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Disqus Shortname not set. Please check settings

Written by EGN NEWS DESK

Captain Vikram Batra’s Important Phone Call | Shershaah | Siddhart Malhotra, Kiara Advani

Captain Vikram Batra’s Important Phone Call | Shershaah | Siddhart Malhotra, Kiara Advani
The winners and losers of the brand new European Commission

The winners and losers of the brand new European Commission